{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260826183640/en/Agenus-Announces-Updated-NEST-Phase-2-Publication-Reporting-Deep-Pathologic-Responses-and-No-Observed-Recurrences-with-Neoadjuvant-BOTBAL-in-Resectable-Colon-Cancer", "message": "News view counter 903212 successfully enlarged"}